A major discovery in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This crucial tumor protector protein is frequently inactivated in several types of cancer, resulting https://meshbookmarks.com/story22050190/mini-antibodies-reactivate-the-p53-protein-new-promising-hope-for-malignant-management